Literature DB >> 28504997

Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes.

Deepthi Alapati1, Zubair H Aghai, Md Jobayer Hossain, Daniel R Dirnberger, Mark T Ogino, Thomas H Shaffer.   

Abstract

OBJECTIVE: Describe practice variations in ventilator strategies used for lung rest during extracorporeal membrane oxygenation for respiratory failure in neonates, and assess the potential impact of various lung rest strategies on the duration of extracorporeal membrane oxygenation and the duration of mechanical ventilation after decannulation. DATA SOURCES: Retrospective cohort analysis from the Extracorporeal Life Support Organization registry database during the years 2008-2013. STUDY SELECTION: All extracorporeal membrane oxygenation runs for infants less than or equal to 30 days of life for pulmonary reasons were included. DATA EXTRACTION: Ventilator type and ventilator settings used for lung rest at 24 hours after extracorporeal membrane oxygenation initiation were obtained. DATA SYNTHESIS: A total of 3,040 cases met inclusion criteria. Conventional mechanical ventilation was used for lung rest in 88% of cases and high frequency ventilation was used in 12%. In the conventional mechanical ventilation group, 32% used positive end-expiratory pressure strategy of 4-6 cm H2O (low), 22% used 7-9 cm H2O (mid), and 43% used 10-12 cm H2O (high). High frequency ventilation was associated with an increased mean (SEM) hours of extracorporeal membrane oxygenation (150.2 [0.05] vs 125 [0.02]; p < 0.001) and an increased mean (SEM) hours of mechanical ventilation after decannulation (135 [0.09] vs 100.2 [0.03]; p = 0.002), compared with conventional mechanical ventilation among survivors. Within the conventional mechanical ventilation group, use of higher positive end-expiratory pressure was associated with a decreased mean (SEM) hours of extracorporeal membrane oxygenation (high vs low: 136 [1.06] vs 156 [1.06], p = 0.001; mid vs low: 141 [1.06] vs 156 [1.06]; p = 0.04) but increased duration of mechanical ventilation after decannulation in the high positive end-expiratory pressure group compared with low positive end-expiratory pressure (p = 0.04) among survivors.
CONCLUSIONS: Wide practice variation exists with regard to ventilator settings used for lung rest during neonatal respiratory extracorporeal membrane oxygenation. Use of high frequency ventilation when compared with conventional mechanical ventilation and use of low positive end-expiratory pressure strategy when compared with mid positive end-expiratory pressure and high positive end-expiratory pressure strategy is associated with longer duration of extracorporeal membrane oxygenation. Further research to provide evidence to drive optimization of pulmonary management during neonatal respiratory extracorporeal membrane oxygenation is warranted.

Entities:  

Mesh:

Year:  2017        PMID: 28504997      PMCID: PMC5503755          DOI: 10.1097/PCC.0000000000001171

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  17 in total

1.  Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization.

Authors:  S R Hintz; D M Suttner; A M Sheehan; W D Rhine; K P Van Meurs
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  Protocols to improve the care of critically ill pediatric and adult patients.

Authors:  Maureen O Meade; E Wesley Ely
Journal:  JAMA       Date:  2002-11-27       Impact factor: 56.272

Review 3.  ECMO for neonatal respiratory failure.

Authors:  K Rais Bahrami; Krisa P Van Meurs
Journal:  Semin Perinatol       Date:  2005-02       Impact factor: 3.300

4.  Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome.

Authors:  J M Kennaugh; J P Kinsella; S H Abman; J A Hernandez; S G Moreland; A A Rosenberg
Journal:  J Perinatol       Date:  1997 Sep-Oct       Impact factor: 2.521

Review 5.  The diseases treated with ECMO: focus on PPHN.

Authors:  Kathryn N Farrow; Paola Fliman; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2005-02       Impact factor: 3.300

Review 6.  Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy.

Authors:  Brian J Fligor; Marilyn W Neault; Charlotte H Mullen; Henry A Feldman; Dwight T Jones
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

7.  Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.

Authors:  Paul H Lipkin; Dennis Davidson; Lynn Spivak; Richard Straube; Jared Rhines; C T Chang
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

8.  Extracorporeal Life Support Organization Registry Report 2012.

Authors:  Matthew L Paden; Steven A Conrad; Peter T Rycus; Ravi R Thiagarajan
Journal:  ASAIO J       Date:  2013 May-Jun       Impact factor: 2.872

9.  A comparison of radiographic signs of pulmonary inflammation during ECMO between silicon and poly-methyl pentene oxygenators.

Authors:  Espeed Khoshbin; Anthony E W Dux; Hilliary Killer; Andrzej W Sosnowski; Richard K Firmin; Giles J Peek
Journal:  Perfusion       Date:  2007-01       Impact factor: 1.972

10.  Diverse Morbidity and Mortality Among Infants Treated with Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Sigrid Bairdain; Peter Betit; Nancy Craig; Kimberlee Gauvreau; Peter Rycus; Jay M Wilson; Ravi Thiagarajan
Journal:  Cureus       Date:  2015-04-07
View more
  2 in total

1.  Acute lung injury: how to stabilize a broken lung.

Authors:  Gary F Nieman; Penny Andrews; Joshua Satalin; Kailyn Wilcox; Michaela Kollisch-Singule; Maria Madden; Hani Aiash; Sarah J Blair; Louis A Gatto; Nader M Habashi
Journal:  Crit Care       Date:  2018-05-24       Impact factor: 9.097

2.  Role of Lung Function Monitoring by the Forced Oscillation Technique for Tailoring Ventilation and Weaning in Neonatal ECMO: New Insights From a Case Report.

Authors:  Genny Raffaeli; Chiara Veneroni; Stefano Ghirardello; Anna Lavizzari; Sofia Passera; Fabio Mosca; Giacomo Cavallaro; Raffaele L Dellacà
Journal:  Front Pediatr       Date:  2018-11-01       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.